[Effects of antianginal agents on myocardial blood flow].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D002121:Calcium Channel Blockers / Q000494:pharmacology; D003326:Coronary Circulation / Q000187:drug effects*; D006801:Humans; D008981:Molsidomine; D009566:Nitrates / Q000494:pharmacology; D010099:Oxyfedrine / Q000494:pharmacology; D013558:Sydnones / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D009566:Nitrates; D013558:Sydnones; D014665:Vasodilator Agents; D008981:Molsidomine; D010099:Oxyfedrine
Wirkung antianginöser Substanzen auf die Myokarddurchblutung.